Back to Search
Start Over
Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells.
- Source :
-
Experimental cell research [Exp Cell Res] 2006 Jul 15; Vol. 312 (12), pp. 2203-13. Date of Electronic Publication: 2006 Apr 21. - Publication Year :
- 2006
-
Abstract
- Colon cancer progression is associated with the activation of protein kinase C (PKC), the downregulation of functional E-cadherin and an increased expression of the serine protease urokinase (u-PA) and its receptor (u-PAR). HT29-M6 intestinal epithelial cells represent an in vitro model to study colon cancer progression. These cells are induced to scatter and to invade by phorbol esters. Using proteolytic and cell signaling inhibitors, we show that HT29-M6 cells require plasminogen for the acquisition of the scattering response to PMA. Our results indicate that, prior to inducing a state of competency for plasminogen-dependent scattering, PMA triggers an ordered succession of events where upregulation of the activity of u-PA precedes proteolysis of u-PAR and active degradation of the extracellular matrix (ECM). These events poise HT29-M6 cells to a scatter-competent state that allows the subsequent localized proteolytic activation of plasminogen to plasmin, required for the execution of scattering. Finally, we show that, in addition to its enzymatic activity directed at the degradation of ECM, plasmin generates an intracellular signal resulting in the phosphorylation of ERK 1/2. For a full motogenic activity, plasmin requires this signal since the use of a MEK inhibitor (PD98059) specifically blocks the plasmin-dependent phase of cell scattering. Our observations suggest that plasmin exerts a dual role in PMA-induced scattering of HT29-M6 cells, one directed extracellularly to promote proteolysis of the ECM and one directed to generate intracellular signaling.
- Subjects :
- Aminocaproic Acid pharmacology
Cell Movement drug effects
Colonic Neoplasms metabolism
Colonic Neoplasms pathology
Culture Media, Serum-Free pharmacology
Enzyme Inhibitors pharmacology
Extracellular Matrix metabolism
Extracellular Signal-Regulated MAP Kinases antagonists & inhibitors
Extracellular Signal-Regulated MAP Kinases metabolism
Fibrinolysin metabolism
Fibrinolysin pharmacology
Flavonoids pharmacology
HT29 Cells
Hepatocyte Growth Factor pharmacology
Humans
Integrin beta1 metabolism
Pertussis Toxin pharmacology
Phosphorylation drug effects
Plasminogen deficiency
Plasminogen metabolism
Plasminogen pharmacology
Plasminogen Activator Inhibitor 1 pharmacology
Protein Kinase C-alpha antagonists & inhibitors
Protein Kinase C-alpha metabolism
Pyrazoles pharmacology
Pyrimidines pharmacology
Receptors, Cell Surface metabolism
Receptors, Urokinase Plasminogen Activator
Signal Transduction drug effects
Urokinase-Type Plasminogen Activator antagonists & inhibitors
Urokinase-Type Plasminogen Activator metabolism
Cell Movement physiology
Fibrinolysin physiology
Signal Transduction physiology
Tetradecanoylphorbol Acetate pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0014-4827
- Volume :
- 312
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Experimental cell research
- Publication Type :
- Academic Journal
- Accession number :
- 16631161
- Full Text :
- https://doi.org/10.1016/j.yexcr.2006.03.017